Antisense Oligonucleotides to Proliferating Cell Nuclear Antigen and Ki-67 Inhibit Human Mesangial Cell Proliferation

Journal of the American Society of Nephrology

Volumn 7, Issue 10, 1996, Pages 2219-2229

  Maeshima, Yohei ^a   Kashihara, Naoki ^a   Sugiyama, Hitoshi ^a   Makino, Hirofumi ^a   Ota, Zensuke ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antisense therapy; Growth factor; Ki 67; Mesangial cell proliferation; PCNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLINE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOPATHY; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL;

EID: 0030410931     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Striker LJ, Peten EP, Elliot SJ, Doi T, Striker GE: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 1991;64:446-456.
2. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 1992;41:1134-1142.
3. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
4. Kashihara N, Watanabe U, Makino H, Kanwar YS: Interleukin-1-induced alterations in glomerular proteoglycans: Biochemical and tissue autoradiographic aspects. J Am Soc Nephrol 1992;3:203-213.
5. Johnson RJ, Raines E, Floege J, et al.: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor. J Exp Med 1992;175:1413-1416.
6. Prelich G, Stillman B: Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 1988;53:117-126.
7. Prelich G, Tan CK, Kostura M, et al.: Functional identity of proliferating cell nuclear antigen and a DNA polymerase δ auxiliary protein. Nature (Lond) 1992;326:517-520.
8. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature (Lond) 1987;326:515-517.
9. Schluter C, Duchrow M, Wohlenberg C, et al.: The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. Cell Biol 1993;123:513-522.
10. Striker GE, Striker LJ: Glomerular cell culture. Lab Invest 1985;53:122-131.
11. Lovett DH, Sterzel RB, Ryan JL, Kashgarian M: Neutral proteinase activity produced in vitro by cells of the glomerular mesangium. Kidney Int 1983;23:342-349.
12. Sterzel RB, Lovett DH, Foellmer HG, Perfetto MC, Blemesdefer D, Kashgarian M: Mesangial cell hillocks: Nodular foci of exaggerated growth of cells and matrix in prolonged cultures. Am J Pathol 1986;125:130-140.
13. Felgner PL, Gadek TR, Holm M, et al.: Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-7417.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-159.
15. Onbe T, Kashihara N, Yamasaki Y, Makino H, Ota Z: Expression of mRNAs of cytokines and growth factors in the experimental glomerulonephritis. Res Com Mol Pathol Pharmacol 1994;86:131-138.
16. Travali S, Ku DH, Rizzo MG, et al.: Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 1989;264:7466-7472.
17. Arcari P, Martinelli R, Salvatore F: The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res 1984;12:9179-9189.
18. Helene C, Toulme J: Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochem Biophys Acta 1990;1049:99-125.
19. Speir E, Epstein SE: Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Circulation 1992;86:538-547.
20. Jaskulski D, DeRiel JK, Mercer WE, Calabretta B, Baserga R: Inhibition of cellular proliferation by antisense oligonucleotides to PCNA cyclin. Science (Washington, DC) 1988;240:1545-1546.
21. Brown KE, Kindy MS, Sonenshein GE: Expression of the c-myb proto-oncogene in bovine vascular smooth muscle cells. J Biol Chem 1992;267:4625-4630.
22. Simons M, Rosenberg RD: Antisense non-muscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992; 70:835-843.
23. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD: Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (Lond) 1992;359:67-70.
24. Morishita R, Gibbons GH, Ellison KE, et al.: Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8478.
25. Benett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI: Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994;93:820-828.
26. Morishita R, Gibbons GH, Ellison KE: Intimal hyperplasia after vascular injury is inhibited by antisense cdk2 kinase oligonucleotides. J Clin Invest 1994;93:1458-1464.
27. Simons M, Edelman ER, Rosenberg RD: Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 1994;93:2351-2356.
28. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 1993;43:547-854.
29. Abbot F, Ryan JJ, Ceska M, Matsushima K, Sarraf CE, Rees AJ: Interleukin-1β stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int 1991;40:597-605.
30. Ruef C, Budde K, Lacy J, et al.: Interleukin-6 is an autocrine growth factor for mesangial cells. Kidney Int 1990;38:249-257.
31. Schultz PJ, DiCorleto PE, Silver BJ, Abboud HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988;255:F674-F684.
32. Floege J, Eng E, Lindner V, Young BA, Reidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic FGF: Release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 1992;90:2362-2369.
33. Mackay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE: Transforming growth factor-β: Murine glomerular receptors and responses to isolated glomerular cells. J Clin Invest 1989;83:1160-1167.
34. Bakris GL, Fairbanks R, Traish AM: Arginine vasopressin stimulates human mesangial cell production of endothelin. J Clin Invest 1991;87:1158-1164.
35. Iida H, Seifert R, Alpers CE, et al.: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991;88:6560-6564.
36. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature (Lond) 1990;346:371-374.
37. Border WA, Noble NA, Yamamoto T, et al.: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature (Lond) 1992;360:361-364.
38. Klagsbrun M, Edelman ER: Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis 1989;9:269-278.
39. Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Washington, DC) 1991;252:1705-1708.
40. Mene P, Dunn MJ: Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int 1990;37:1256-1262.
41. Garg UC, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989;257:F60-F66.
42. Shin SH, Fujiwara Y, Takama T, et al.: Analysis of inositol tris- and tetrakisphosphate in mesangial cells by HPLC. Kidney Int 1989;35:1320-1323.
43. Force T, Kyriakis JM, Avruch J, Bonventre J: Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J Biol Chem 1991;266:6650-6656.
44. Moriyama T, Fujiwara Y, Imai E, et al.: A protein-tyrosine phosphatase gene expression is regulated differently by interleukins and angiotensin II in cultured rat mesangial cells [Abstract]. J Am Soc Nephrol 1991; 2:442A.
45. Liu YC, Marraccino RL, Keng PC, et al.: Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry 1988;28:2967-2974.
46. Bravo R, Bravo HM: Induction of the nuclear protein 'cyclin' in quiescent mouse 3T3 cells stimulated by serum and growth factors: Correlation with DNA synthesis. EMBO (Eur Mol Biol Organ) J 1984;3:3177-3181.
47. Jaskulski D, Gatti C, Travali S, Calabretta B, Baserga R: Regulation of the proliferation cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem 1988;263:10175-10179.
48. Floege J, Eng E, Young BA, et al.: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92: 2952-2962.
49. Witzgall R, Brown D, Schwarz C, Bonventr JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. J Clin Invest 1994;93:2175-2188.
50. Locker AP, Birrell K, Bell JA, et al.: Ki-67 immunore-activity in breast carcinoma: Relationships to prognostic variables and short term survival. Eur J Surg Oncol 1992;18:224-229.
51. Fontana D, Bellina M, Gubetta L, et al.: Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol 1992;148:1149-1151.
52. Wintzer HO, Zipfel I, Monting JS, Hellerich U, von Kleist S: Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-428.
53. Tungekar MF, Gatter KC, Dunnill MS, Mason DJ: Ki-67 immunostaining and survival in operable lung cancer. Histopathology (Oxf) 1991;19:545-550.
54. Holte H, Davies CL, Beiske K, et al.: Ki-67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer 1989;44:975-980.
55. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfeld AG: The prognostic value of Ki-67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988;154:223-235.
56. Gerdes J: Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990;1:99-206.
57. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
58. Schrape S, Jones DB, Wright DH: A comparison of the methods for the determination of the growth fraction in non-Hodgkin's lymphoma. Br J Cancer 1987;55:283-286.
59. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology (Oxf) 1990;17: 489-503.
60. Shaw JP, Kent K, Bird J, Fishback J, Froehler B: Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res 1991;19:747-750.
61. Biro S, Fu YM, Yu ZX, Epstein SE: Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 1993;90:654-658.
62. Dean NM, McKay R, Condon TP, Bennet CF: Inhibition of protein kinase C-α expression in human A549 cells by antisense oligonucleotides inhibits induction of intracellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 1994;269:16416-16424.